Clinical trial · Observational
An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya
Breast Cancer Care (BRECC) Registry - Development of a Breast Cancer Registry to Determine the Magnitude of Breast Cancer and Current Clinical Care Patterns in Kenya
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This observational study, conducted by the Kenya Society for Hematology and Oncology, will develop a Breast Cancer and Care Registry (BRECC) for Kenya. Data on demographic, clinical and pathological characteristics, treatment and clinical outcome will be collected from newly diagnosed breast cancer patients. Breast cancer patients will be recruited into this registry cohort and followed up for a period of not less than five years.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Cohort
Primary outcomes (2)
- measure
- Incidence of breast cancer in Kenya
- timeFrame
- 5 years
- measure
- Breast cancer treatment patterns (drugs/dosage/schedule) in clinical practice in Kenya
- timeFrame
- 5 years
Secondary outcomes (7)
- measure
- Progression-free survival
- timeFrame
- 5 years
- measure
- Overall survival
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically or cytologically confirmed breast cancer * No previous interventional therapy for breast cancer * Ability to provide written informed consent as per GCP and local regulations Exclusion Criteria: * Participation in other clinical study where the diagnosis and treatment protocol is stated prior to enrolment * Inability to assess and follow up patient outcomes, for example quality of life due to psychiatric illness or WHO/ECOG performance status IV or worse
References
Publications (0)
Data not yet available